Seeing Is Believing
Currently out of the existing stock ratings of Jayson Bedford, 313 are a BUY (94.85%), 15 are a HOLD (4.55%), 2 are a SELL (0.61%).
Analyst Jayson Bedford, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 56.96% that have a potential upside of 19.34% achieved within 267 days.
Jayson Bedford’s has documented 641 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on AXGN, Axogen at 25-Sep-2026.
Analyst best performing recommendations are on SENS (SENSEONICS HOLDINGS).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/5/2020. The price target of $85 was fulfilled within 9 days with a profit of $10.69 (14.39%) receiving and performance score of 15.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jan-2017
$135
$37.5 (38.46%)
$135
25 days ago
(08-Sep-2026)
23/35 (65.71%)
$29.48 (27.94%)
340
Hold Since 13-Aug-2026
$130
$32.5 (33.33%)
1 months 20 days ago
(13-Aug-2026)
2/3 (66.67%)
$18.73 (16.83%)
29
Buy Since 28-Jul-2026
$125
$27.5 (28.21%)
$117
2 months 5 days ago
(28-Jul-2026)
3/4 (75%)
$17.73 (16.53%)
150
Buy Since 06-Jun-2019
$112
$14.5 (14.87%)
$136
2 months 16 days ago
(17-Jul-2026)
21/29 (72.41%)
$11.32 (11.24%)
409
Buy Since 19-Sep-2024
$118
$20.5 (21.03%)
$115
2 months 16 days ago
(17-Jul-2026)
4/8 (50%)
$17.32 (17.20%)
120
Which stock is Jayson Bedford most bullish on?
Which stock is Jayson Bedford most reserved on?
What Year was the first public recommendation made by Jayson Bedford?